Announce Date | 05/29/2025 |
EPS Normalized Actual | $1.96 (Beat by $0.17) |
EPS GAAP Actual | $1.96 (Beat by $0.17) |
Revenue Actual | $4.69464B |
Revenue Surprise | Beat by $4694.64M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $9.01 |
EPS GAAP Estimate | $9.01 |
Revenue Estimate | $0.385734389B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 74.82403 | 1.9 | 66.97234 | 81.07252 | 4 |
Dec 2026 | 338.21425 | 0.42 | 194.85942 | 413.38312 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.93 | -8.06826 | 4.69464B | 44.78% | 4299.3M |
FQ4 2024 (Dec 2024) | 13.36 | 4.95001 | 3.9192B | 46.35% | 3580.17M |
FQ3 2024 (Sep 2024) | 0 | -1.54141 | 3.43613B | 22.87% | -1659M |
FQ2 2024 (Jun 2024) | 0 | -1.34259 | 3.12899B | 32.55% | -1400.01M |
FQ1 2024 (Mar 2024) | 7.52 | 2.94503 | 2.59246B | 14.79% | 193.38M |
FQ4 2023 (Dec 2023) | 6.32 | 6.32 | 2.10248B | 7.8% | 2102.48M |
FQ3 2023 (Sep 2023) | 8 | 8 | 2.65042B | 34.82% | 2650.42M |
FQ2 2023 (Jun 2023) | 8.08 | 8.08 | 2.11035B | 100% | 2110.35M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
9.01
Consensus Revenue Estimates
0.385734389B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 23.01976 | -- | 23.01976 | 23.01976 | 1 |
FQ2 2027 (Jun 2027) | 21.3701 | -- | 21.3701 | 21.3701 | 1 |
FQ1 2027 (Mar 2027) | 20.31215 | -- | 20.31215 | 20.31215 | 1 |
FQ4 2026 (Dec 2026) | 11.44917 | -- | 11.11886 | 11.77924 | 0 |
FQ3 2026 (Sep 2026) | 11.29478 | -- | 10.96892 | 11.6204 | 0 |
FQ2 2026 (Jun 2026) | 10.66614 | -- | 10.35842 | 10.97364 | 0 |
FQ1 2026 (Mar 2026) | 9.89803 | 80.5 | 9.61247 | 10.18338 | 0 |
FQ4 2025 (Dec 2025) | 9.14506 | -46.09 | 8.88122 | 9.40871 | 0 |
FQ3 2025 (Sep 2025) | 9.01 | -- | 8.75006 | 9.26975 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 5.68B | -- | 5.68B | 5.68B | 1 |
FQ2 2027 (Jun 2027) | 5.34B | -- | 5.34B | 5.34B | 1 |
FQ1 2027 (Mar 2027) | 5.1B | -- | 5.1B | 5.1B | 1 |
FQ4 2026 (Dec 2026) | 0.48B | -- | 0.47B | 0.49B | 1 |
FQ3 2026 (Sep 2026) | 0.46B | -- | 0.45B | 0.47B | 1 |
FQ2 2026 (Jun 2026) | 0.44B | -- | 0.43B | 0.45B | 1 |
FQ1 2026 (Mar 2026) | 0.42B | -1018.02 | 0.41B | 0.43B | 1 |
FQ4 2025 (Dec 2025) | 0.4B | -874.63 | 0.39B | 0.41B | 0 |
FQ3 2025 (Sep 2025) | 0.39B | -790.8 | 0.38B | 0.39B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 9.99826 | 1.93 | -8.06826 | -418.04% |
FQ4 2024 (Dec 2024) | 8.40999 | 13.36 | 4.95001 | 37.05% |
FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
FQ2 2024 (Jun 2024) | 1.34259 | 0 | -1.34259 | -INF% |
FQ1 2024 (Mar 2024) | 4.57497 | 7.52 | 2.94503 | 39.16% |
FQ4 2023 (Dec 2023) | 6.32 | 6.32 | 100% | |
FQ3 2023 (Sep 2023) | 8 | 8 | 100% | |
FQ2 2023 (Jun 2023) | 8.08 | 8.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.4B | $4.69B | $4299.3M | 91.58% |
FQ4 2024 (Dec 2024) | $0.34B | $3.92B | $3580.17M | 91.35% |
FQ3 2024 (Sep 2024) | $5.1B | $3.44B | $-1659M | -48.28% |
FQ2 2024 (Jun 2024) | $4.53B | $3.13B | $-1400.01M | -44.74% |
FQ1 2024 (Mar 2024) | $2.4B | $2.59B | $193.38M | 7.46% |
FQ4 2023 (Dec 2023) | $0B | $2.1B | $2102.48M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.65B | $2650.42M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.11B | $2110.35M | 100% |